CORRECTING and REPLACING Webcast Alert: GeoPharma Inc. First Quarter ...

Tag : Internet Phone Call

If you are unable to participate during the live webcast, the callwill be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=132430 or http://www.investorcalendar.com
GeoPharma, Inc. is a rapidly growing Bio/Pharma company with adiversified business model participating in 3 main market segments:Specialty Pharma, Manufacturing, and Distribution. The SpecialtyPharma division specializes in the formulation of generic drugs forhuman and veterinary usage and the development of medical devicesused by oncologists and other medical professionals. TheManufacturing and Distribution divisions manufacture, package, anddistribute generic drugs, nutraceuticals, cosmetics, and functionalfood products for companies worldwide.
GeoPharma's growth strategy is to capitalize on its research andmanufacturing expertise to develop medical devices and high margingeneric drug products for niche markets with high barriers toentry. GeoPharma's competitive advantage in these areas is in itsability to navigate the challenges that such market pursuitspresent effectively.
Currently GeoPharma employs over 300 people and operates facilitiesin Florida, Maryland, Pennsylvania, Nevada, Rhode Island, and Texasutilizing over 330,000 sq. ft. of office, warehouse, manufacturingand laboratory facilities. For further information visit the "ForInvestors" section of the GeoPharma website at www.geopharmainc.com .
GeoPharma Inc.
Alexander Nachman, 727-471-0850, ext. 243
ir@geopharmainc.com